Condition

Transformed Small Cell Lung Cancer clinical trials and research

• 2Clinical trials
• 12Countries

All recruiting trials (2)

• PF-08634404 with or without chemotherapy for adults with transformed small cell lung cancer

  This will try the experimental drug PF-08634404 by itself and together with chemotherapy in adults whose EGFR-mutated non-small cell lung cancer has turned into transformed small cell lung cancer.

  Recruiting at 55 sites Phase 2 Pfizer · Duarte, California and 60 other locations · NCT07476287

• Lurbinectedin with Osimertinib for transformed small cell lung cancer

  This study tests a drug combo (lurbinectedin plus osimertinib) to see if it can help adults whose EGFR-mutated non-small cell lung cancer has transformed into small cell lung cancer.

  Recruiting Phase 1/2 Indiana University · Indianapolis, Indiana · NCT07153055

Related topics

Quick answers

How many Transformed Small Cell Lung Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in United States (2 trials), Australia (1 trial), Brazil (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →